Kelly Financial Services’s Korro Bio KRRO Stock Holding History

Kelly Financial Services’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$34	–	466
2024 Q2	$34	Hold	1	–	–	﹤0.01%	779
2024 Q1	$90	Hold	1	–	–	﹤0.01%	767
2023 Q4	$48	Hold	1	–	–	﹤0.01%	765
2023 Q3	$26	Hold	1	–	–	﹤0.01%	752
2023 Q2	$24	Hold	1	–	–	﹤0.01%	718
2023 Q1	$35	Hold	1	–	–	﹤0.01%	690
2022 Q4	$270	Hold	1	–	–	﹤0.01%	631
2022 Q3	$125	Hold	1	–	–	﹤0.01%	665
2022 Q2	$105	Hold	1	–	–	﹤0.01%	660
2022 Q1	$148	Hold	1	–	–	﹤0.01%	650
2021 Q4	$359	Hold	1	–	–	﹤0.01%	640
2021 Q3	$494	Sell	1 -13	-93%	-$5.12K	﹤0.01%	602
2021 Q2	$70K	Buy	14 +13	+1,300%	+$6.35K	﹤0.01%	423
2021 Q1	$665	Hold	1	–	–	﹤0.01%	569
2020 Q4	$2.47K	Hold	1	–	–	﹤0.01%	444
2020 Q3	$1.34K	Hold	1	–	–	﹤0.01%	462
2020 Q2	$1.63K	Hold	1	–	–	﹤0.01%	458
2020 Q1	$1.25K	Hold	1	–	–	﹤0.01%	434
2019 Q4	$1.23K	Buy	+1	New	+$778	﹤0.01%	463

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Kelly Financial Services's KRRO Position: Q3 2024 in Review

Kelly Financial Services sold out of Korro Bio (KRRO) in Q3 2024, closing a stake of 1 share — an estimated $34 sold.

Kelly Financial Services first reported a position in KRRO in Q4 2019 and held it in 19 quarters. The position peaked at $70K in Q2 2021. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2024.

Kelly Financial Services reported no remaining Korro Bio position as of Q3 2024 after selling out during the quarter.
Kelly Financial Services sold 1 Korro Bio share in Q3 2024, an estimated $34.
Kelly Financial Services first reported a position in Korro Bio in Q4 2019 and held it in 19 quarters.
Kelly Financial Services's Korro Bio position peaked at $70K in Q2 2021.
71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.